New Atlas

Dog licking its snout

Cancer vaccine for dogs almost doubles survival rates in clinical trial

Scientists at Yale University adapted existing human cancer treatments to find a new version that could benefit both humans and dogs. After conducting multiple clinical trials involving over 300 dogs over the past eight years, the researchers say that their canine cancer vaccine has almost doubled the 12-month survival rate for dogs with some types of cancer.

Cancer vaccine for dogs almost doubles survival rates in clinical trial More

Scientist holding new ultrathin pacemaker

Scientists invent ultrathin, wireless, light-operated pacemaker that cuts invasive surgery

Scientists at the University of Chicago have developed a new pacemaker that’s thinner than a human hair, wireless, and operated entirely by light from an optic fiber. The non-invasive device could help regulate heart activity or even stimulate neurons in a set pattern to treat symptoms of conditions like Parkinson’s.

Scientists invent ultrathin, wireless, light-operated pacemaker that cuts invasive surgery More

3d illustration of gut and stomach pain

79% of Crohn’s disease patients in remission after early intervention

Led by researchers from the University of Cambridge, a clinical trial examined the effectiveness of giving the immunotherapy drug infliximab earlier, as soon as possible after diagnosis. They employed what’s called a ‘top-down’ strategy, meaning the drug was given straight after diagnosis regardless of the patient’s symptom severity. They found that this early intervention significantly reduces complications of this often debilitating disease, including the need for surgery by a factor of 10.

79% of Crohn’s disease patients in remission after early intervention More

Solar panels

Turkish scientists develop “bumpy” solar panel concept that can harvest up to 66% more energy

Solar cell efficiency may get a bump from bumps. New research from Turkey’s Abdullah Gül University suggests that building tiny domes into the surface of organic solar cells could boost their efficiency by up to two-thirds, while capturing light from a wider angle.

Turkish scientists develop “bumpy” solar panel concept that can harvest up to 66% more energy More

Aerial view of container ship

Decarbonization containers turn 78% of marine emissions into limestone in new pilot

A remarkable pilot project installed on a 787-ft. container ship has proven it’s possible to capture emissions from the smokestacks of cargo ships with 78% efficiency and convert the CO2 into limestone pebbles, which can be offloaded and sold. London startup Seabound, funded by a US$1.5-million grant from the UK Government, partnered up with global shipping company Lomar to install the carbon capture equipment on one of its older and dirtier-burning ships, a medium-sized vessel capable of carrying more than 3,200 shipping containers.

Decarbonization containers turn 78% of marine emissions into limestone in new pilot More

Assortment of pills

Novel AI model rapidly determines if an antidepressant will work

Amsterdam University Medical Center (UMC) and Radboud UMC researchers have developed an algorithm that, based on patient MRI scans and other data, can determine within a week if a particular antidepressant will, offering faster relief and minimizing often painful and damaging side effects. “This is important news for patients,” said Liesbeth Reneman, Professor of Neuroradiology at Amsterdam UMC. “Normally, it takes six to eight weeks before it is known whether an antidepressant will work.”

Novel AI model rapidly determines if an antidepressant will work More

Depiction of nerve cells

Researchers discover an effective non-opioid treatment for nerve pain

Many available pain medications aren’t effective in reducing this often-debilitating type of chronic pain. However, researchers at the University of Texas at Austin (UT Austin), in collaboration with UT Dallas and the University of Miami, may have advanced the treatment of neuropathic pain by discovering a molecule that reduces mechanical hypersensitivity in mice.

Researchers discover an effective non-opioid treatment for nerve pain More

Person receiving nasal spray

Novel nasal COVID-19 vaccine offers longer, better immunity than jabs

Researchers at Duke-NUS Medical School in Singapore have developed an intranasal COVID-19 vaccine that enhances the immune system’s response to the virus, providing longer-lasting, greater protection than vaccine injections, even against new and emerging variants. The novel vaccine candidate could mean fewer boosters in future.

Novel nasal COVID-19 vaccine offers longer, better immunity than jabs More

Molecule of the human hormone glucagon

Australian scientists regenerate diabetics’ damaged cells to produce insulin

For many years, research has focused on identifying novel therapies that stimulate beta-cell growth and function to restore insulin production in type 1 diabetics. Now, researchers at the Baker Heart and Diabetes Institute in Melbourne have brought us a step closer to making this a reality, regenerating damaged pancreatic cells so they can produce insulin and functionally respond to blood glucose levels. The novel therapeutic approach has the potential to become the first disease-modifying treatment for type 1 diabetes.

Australian scientists regenerate diabetics’ damaged cells to produce insulin More